Inventor

LETHE BERNARD

BE15 patents

⚠️ This page may combine multiple inventors who share the name “LETHE BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUDWIG INST CANCER RES

13 patents

US5612201AMar 18, 1997

Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor

LUDWIG INST CANCER RES127 citations95

US5487974AJan 30, 1996

Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells

LUDWIG INST CANCER RES59 citations95

US5744316AApr 28, 1998

Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products

LUDWIG INST CANCER RES16 citations78

US6669946B2Dec 30, 2003

Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals

LUDWIG INST CANCER RES5 citations73

US5512437AApr 30, 1996

Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3

LUDWIG INST CANCER RES11 citations71

US5763165AJun 9, 1998

Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3

LUDWIG INST CANCER RES14 citations70

US7157091B1Jan 2, 2007

MAGE-A1 peptides presented by HLA class II molecules

LUDWIG INST CANCER RES4 citations62

US5843688ADec 1, 1998

Isolated tyrosinase derived peptides and uses thereof

LUDWIG INST CANCER RES2 citations62

US6794131B1Sep 21, 2004

Lage-1 tumor associated nucleic acids

LUDWIG INST CANCER RES3 citations61

US6284476B1Sep 4, 2001

Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals

LUDWIG INST CANCER RES0 citations51

LUDWIG INST FOR CANCER RES LTD

2 patents

US7998483B2Aug 16, 2011

Lage-1 tumor associated nucleic acids

LUDWIG INST FOR CANCER RES LTD0 citations50

US7563870B2Jul 21, 2009

LAGE-1 tumor associated nucleic acids

LUDWIG INST FOR CANCER RES LTD0 citations50

LETHE BERNARD

LUDWIG INST CANCER RES

Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor

Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells

Isolated, tyrosinase derived peptides and uses thereof

Isolated, tyrosinase derived peptides and uses thereof

Mage-A3 peptides presented by HLA class molecules

Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products

Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals

Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3

Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3

MAGE-A1 peptides presented by HLA class II molecules

Isolated tyrosinase derived peptides and uses thereof

Lage-1 tumor associated nucleic acids

Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals

LUDWIG INST FOR CANCER RES LTD

Lage-1 tumor associated nucleic acids

LAGE-1 tumor associated nucleic acids